— Know what they know.
Not Investment Advice

RYOIX

Rydex Biotechnology Inv
1W: -2.3% 1M: -4.2% 3M: +1.2% YTD: +24.0% 1Y: +24.4% 3Y: +40.6% 5Y: +8.6%
$93.21
+0.07 (+0.08%)
 
Weekly Expected Move ±2.6%
$88 $91 $93 $96 $98
ETF NASDAQ · AUM $98.4M
Key Statistics
AUM$98M
Holdings70
Top 10 Wt36.7%
Volume0
Avg Volume0
Beta0.68
Portfolio Fundamentals
P/E38.9
P/B8.4
Div Yield0.49%
ROE10.4%
% Profitable43%
Inception1998-03-31
Sector Allocation
Healthcare 97.2%
Other 1.5%
Financial Services 0.5%
Top 10 Holdings
# Name Ticker Weight % Market Value Shares
1 AbbVie Inc. 4AB.DE 7.39% $10.0M 45,923
2 Amgen Inc. 4332.HK 5.23% $7.1M 20,093
3 Gilead Sciences Inc. GILD.SW 4.96% $6.7M 48,042
4 Vertex Pharmaceuticals Incorporated VX1.DE 4.01% $5.4M 12,119
5 Regeneron Pharmaceuticals, Inc. 0R2M.L 3.56% $4.8M 6,224
6 Alnylam Pharmaceuticals Inc. 0HD2.L 2.60% $3.5M 10,632
7 Insmed Inc 0JAV.L 2.45% $3.3M 20,277
8 BEONE MEDICINES LTD BGNE 2.29% $3.1M 10,395
9 NATERA INC NTRA 2.09% $2.8M 14,145
10 United Therapeutics Corporation UTHR 2.07% $2.8M 4,711

Recent Holding Changes

Date Holding Change Details
2026-02-28 HALO New —
2026-02-28 RNAM New —
2026-02-28 ALKS New —
2026-02-28 SLNO New —
2026-02-28 MEDP New —

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms